Compare IDEXX Laboratories, Inc. (IDXX) vs MGM Resorts International (MGM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs MGM Resorts International — how do they compare? IDEXX Laboratories, Inc. trades at $563.81 (market cap $44.48B), while MGM Resorts International trades at $45.71 (market cap $11.86B). The key difference: IDEXX Laboratories, Inc. is far larger — about 3.8× MGM Resorts International's market cap, and MGM Resorts International pays a 0.03% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | MGM | |
|---|---|---|
Market Cap | $44.48B | $11.86B |
Sector | Health | Consumer Cyclical |
52-Week High | $766.68 | $50.69 |
52-Week Low | $520.87 | $30.72 |
Enterprise Value | $45.38B | $40.90B |
Dividend Yield | — | 0.03% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories trades at $552.46, down 2.64% today, with neutral technical signals but strong fundamental performance. The company maintains robust profitability with 24.63% net margins and has beaten earnings expectations for three consecutive quarters. Recent news highlights AI integration in medical devices and upcoming Q2 2026 results on August 4, 2026. The stock shows consistent revenue growth from $3.4B in 2022 to $4.3B in 2025.
Outlook remains positive given earnings momentum and analyst consensus, though elevated valuation ratios (P/E 41.49) pose risks. Key catalysts include Q2 earnings release and continued AI adoption in veterinary diagnostics. Primary risks involve competitive pressures and market volatility affecting premium valuations.
MGM trades at $45.67, down 1.0% today, with a neutral technical stance and mixed earnings history. The company reported $17.54B revenue in 2025 but net income fell to $206M, with profit margins narrowing. Recent news highlights acquisition interest from Barry Diller at $48.30 per share, creating investor uncertainty. Cash flow trends show improving operational strength, though net cash flow remains negative.
Outlook is balanced: potential upside exists from the acquisition offer and steady revenue, but risks include declining profitability and high debt. Analysts are split evenly between Buy and Hold, with a $48.93 consensus target suggesting modest upside. Investors should weigh takeover prospects against fundamental pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About MGM Resorts International
MGM Resorts is the largest resort operator on the Las Vegas Strip with 35,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Cosmopolitan, Luxor, New York-New York, and CityCenter. The Strip contributed approximately 49% of total EBITDAR in the prepandemic year of 2019. MGM also owns U.S. regional assets, which represented 29% of 2019 EBITDAR. we estimate MGM's U.S. sports and iGaming operations are currently a mid-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM Macau casinos with a new property that opened on the Cotai Strip in early 2018. Further, we estimate MGM will open a resort in Japan in 2027.
Read more on MGM →
